A. “Alzheimer’s-related Resource Centers for Minority Aging Research (AD/ADRD RCMAR) (P30 Clinical Trial Optional),” (RFA-AG-23-025, a reissue of RFA-AG-18-002, National Institute on Aging, application deadline Oct. 21, 2022). . Note: There are two companion funding announcements (follow the link under “Companion Funding Opportunity”): “Resource Centers for Minority Aging Research (RCMAR) (P30 Clinical Trial Optional),” (RFA-AG-23-026); and, “Resource Centers for Minority Aging Research (RCMAR) Coordinating Center (U24 Clinical Trial Optional),” (RFA-AG-23-027).
grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-025.html
B. “Early-Stage Therapy Development for ADRD (R61/R33 Clinical Trial Not Allowed),” (RFA-NS-22-059, National Institute on Aging, in conjunction with other agencies, application deadline Oct. 31, 2022).
grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-059.html
C. “HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional),” (RFA-NS-23-003, a reissue of RFA-NS-22-016, National Institute on Aging, in conjunction with other agencies, application deadlines Oct. 10, 2022, June 13, 2023, June 10, 2024, and June 9, 2025).
grants.nih.gov/grants/guide/rfa-files/RFA-NS-23-003.html
D. “Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional),” (RFA-OD-22-014, a Reissue of RFA-OD-19-013, National Institute on Aging, in conjunction with other agencies, application deadlines September 30, 2022 and August 15, 2024).
